Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis

J Yarmolinsky, V Díez-Obrero, TG Richardson… - PLoS …, 2022 - journals.plos.org
Background Epidemiological studies have reported conflicting findings on the potential
adverse effects of long-term antihypertensive medication use on cancer risk. Naturally …

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

J Yarmolinsky, E Bouras, A Constantinescu, K Burrows… - Diabetologia, 2023 - Springer
Aims/hypothesis Epidemiological studies have generated conflicting findings on the
relationship between glucose-lowering medication use and cancer risk. Naturally occurring …

The evolution of mendelian randomization for investigating drug effects

D Gill, S Burgess - PLoS medicine, 2022 - journals.plos.org
Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky
and colleagues investigating the associations between genetically-proxied inhibition of …

Searching for cancer-associated gene polymorphisms: promises and obstacles

EN Imyanitov, AV Togo, KP Hanson - Cancer letters, 2004 - Elsevier
Low-penetrance genetic variations appear to form the most essential component of the
heritability of cancer risk. Search for relevant polymorphic candidates faces significant …

Association of hypertension drug target genes with blood pressure and hypertension in 86 588 individuals

AD Johnson, C Newton-Cheh, DI Chasman… - …, 2011 - Am Heart Assoc
We previously conducted genome-wide association meta-analysis of systolic blood
pressure, diastolic blood pressure, and hypertension in 29 136 people from 6 cohort studies …

A compendium of genome-wide associations for cancer: critical synopsis and reappraisal

JPA Ioannidis, P Castaldi… - JNCI: Journal of the …, 2010 - academic.oup.com
Abstract Since 2007, genome-wide association (GWA) studies have identified numerous
well-supported, novel genetic risk loci for common cancers; however, there are concerns …

Quantifying the genetic correlation between multiple cancer types

S Lindström, H Finucane, B Bulik-Sullivan… - … Biomarkers & Prevention, 2017 - AACR
Background: Many cancers share specific genetic risk factors, including both rare high-
penetrance mutations and common SNPs identified through genome-wide association …

Genome-wide association studies: how predictable is a person's cancer risk?

DH Roukos - Expert review of anticancer therapy, 2009 - Taylor & Francis
From overenthusiasm to scientific assessment and hard reality, the time required for this
transiton has recently been drastically shortened. As high-throughput screening technology …

Genome-wide association studies in cancer—current and future directions

CC Chung, WCS Magalhaes… - …, 2010 - academic.oup.com
Genome-wide association studies (GWAS) have emerged as an important tool for
discovering regions of the genome that harbor genetic variants that confer risk for different …

Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review

L Jing, L Su, BZ Ring - PloS one, 2014 - journals.plos.org
The clinical use of genetic variation in the evaluation of cancer risk is expanding, and thus
understanding how determinants of cancer susceptibility identified in one population can be …